ConductScience.org, home

Paper4138541

New inhibitor of reagin-mediated anaphylaxis.

Broughton BJ and 9 others. Nature, 1974. Cited by 41 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. New inhibitor of reagin-mediated anaphylaxis. Papers, record 4138541. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4138541

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
New inhibitor of reagin-mediated anaphylaxis.
PubMed
Journal
Nature
PubMed
Year
1974
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
41
iCite
Relative citation ratio, by iCite
1.45
iCite
Revised in PubMed
2019-06-17
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Broughton BJB J
2Chaplen PP
3Knowles PP
4Lunt EE
5Pain DLD L
6Wooldridge KRK R
7Ford RR
8Marshall SS
9Walker JLJ L
10Maxwell DRD R

Source PubMed

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Histamine ReleaseMajor topic
Immunoglobulin EMajor topic
ReaginsMajor topic
SRS-AMajor topic
Anaphylaxis
Animals
Asthma
Aza Compounds
Bronchial Spasm
Guinea Pigs
Immunity, Maternally-Acquired
Lung
Passive Cutaneous Anaphylaxis
Purinones
Rats
Xanthenes

Source PubMed

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 41 citations.

PMIDTitleJournalYearIn PapersSource
25,780,785The role of phosphodiesterase inhibitors in the management of pulmonary vascular diseases.Glob Cardiol Sci Pract2014https://conductscience.org/library/papers/25780785PubMed
7,025,596Ro 21-7634, a new antiallergic agent with potent oral activity.Agents Actions1981https://conductscience.org/library/papers/7025596PubMed
6,326,922Cyclic GMP mediates neurogenic relaxation in the bovine retractor penis muscle.Br J Pharmacol1984https://conductscience.org/library/papers/6326922PubMed
6,168,323Effects of cyclic AMP- and cyclic GMP- phosphodiesterase inhibitors on immunological release of histamine and on lung contraction.Br J Pharmacol1981https://conductscience.org/library/papers/6168323PubMed
6,159,030The activity of sodium cromoglycate analogues in human lung in vitro: a comparison with rat passive cutaneous anaphylaxis and clinical efficacy.Br J Pharmacol1980https://conductscience.org/library/papers/6159030PubMed
974,319The pharmacology of anaphylaxis in the chicken intestine.Br J Pharmacol1976https://conductscience.org/library/papers/974319PubMed
56,972Cromoglycate and other antiallergic drugs: a possible mechanism of action.Br Med J1976https://conductscience.org/library/papers/56972PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/4138541

GET https://conductscience.org/api/papers/v1/4138541/authors